and adult TGF-␤1-deficient animals have abnormal myelin (Day et al., 2003). In most cell types, active TGF-␤s bind to heteromeric complexes between type I and type II TGF-␤ receptors (T␤R-I, T␤R-II). T␤R-I phosphorylates
We show that Ski is highly and selectively expressed by myelinating Schwann cells in vivo and induces the expression of genes encoding myelin proteins. If Ski is absent, the expression of myelin-related genes is reduced and the formation of peripheral myelin is abolished. Thus, Ski is a crucial component of the signaling machinery regulating PNS myelination. with growth arrest of cultured Schwann cells. 2B ) but had no effect on GGF-or bFGF-mediated proliferation. In addition, Ski also significantly decreased the proliferation rate of Schwann cells in medium containing 10% FCS. These data indicate a specific antagonistic function of Ski in TGF-␤1-mediated Schwann cell proliferation.
Results

Ski Is Upregulated by Growth-Arrested Schwann Cells
Equal amounts of protein extracts controlled by ␤-actin detection (lower panel). Positive control: protein extract of rat Schwann cells transfected with a Ski expression plasmid (lane 3).
Ski Specifically Antagonizes TGF-␤1-Mediated Schwann Cell Proliferation and Prevents Reentry into the Cell Cycle
To investigate whether exogenous Ski-expressing cells are able to reenter the cell cycle after addition of growth factors, parallel cultures were transfected with a Ski or an EGFP expression vector and maintained for 3 days in minimal medium containing 0.5% FCS to achieve growth arrest ( Figure 2C ). Subsequently, the cells were reinduced to proliferate by adding various proliferation-promoting media, including Schwann cell medium containing 10% FCS or minimal media supplemented with GGF, TGF-␤1, or bFGF. Cells were cultured for an additional 2 days, and the percentage of dividing cells was determined by BrdU incorporation for 16 hr. Regardless of the growth-promoting media tested, a significantly lower number of exogenous Ski-expressing cells reentered the cell cycle ( Figure 2C , gray bars) compared to EGFP-expressing cells ( Figure 2C , black bars). Thus, Ski overexpression blocks Schwann cells from reentering the cell cycle, irrespective of the growth factors used to induce proliferation. tures were additionally postfixed and permeabilized in 100% methanol at Ϫ20ЊC for 5 min. Unspecific binding was blocked for at least in minimal medium plus 0.5% FCS. Minimal medium: DMEM/F12 (GIBCO), human apo-transferrin (100 g/ml), progesterone (60 ng/ 30 min in PBS containing 10% goat serum, 1% BSA, and 0.3% Triton X-100. Primary antibodies against Ski (1:100; Upstate Biotechml), insulin (5 g/ml), putrescine (16 g/ml), L-thyroxin (400 ng/ml), selenium (160 ng/ml), triiodothyronine (10 ng/ml), and 300 g/ml BSA nology), Ki-67 (1:10; DAKO), MBP (1:500; Roche), MAG (1:1000; gift of M.B.Tropak, S.Lunenfeld Research Institute, Toronto, Canada), (Fluka). Supplements were from Sigma, unless stated otherwise. Schwann cell growth factors: human recombinant GGF (20 ng/ml), and p75 (1:300; Chemicon) were incubated in blocking buffer overnight at 4ЊC, followed by incubation with secondary antibodies in TGF-␤1 (10 ng/ml; R&D Systems), and bFGF (10 ng/ml; PeproTech).
TGF-␤1 Prevents Ski Expression in Myelinating Cocultures
For DRG explant cultures, DRGs were excised (E19.5) and plated blocking buffer for 1 hr at room temperature. BrdU labeling and detection was carried out according to the manufacturer's instruc
